163 related articles for article (PubMed ID: 22389016)
21. A rare case of GATA1 negative chemoresistant acute megakaryocytic leukemia in an 8-month-old infant with trisomy 21.
Stepensky P; Brooks R; Waldman E; Revel-Vilk S; Izraeli S; Resnick I; Weintraub M
Pediatr Blood Cancer; 2010 Jul; 54(7):1048-9. PubMed ID: 20108342
[TBL] [Abstract][Full Text] [Related]
22. Acute megakaryoblastic leukemia without GATA1 mutation after transient myeloproliferative disorder in an infant without Down syndrome.
Inaba H; Londero M; Maurer SH; Onciu M; Ge Y; Taub JW; Rubnitz JE; Raimondi SC
J Clin Oncol; 2011 Mar; 29(9):e230-3. PubMed ID: 21205752
[No Abstract] [Full Text] [Related]
23. Erythroblastic and/or megakaryoblastic leukemia in Down syndrome: treatment with low-dose arabinosyl cytosine.
Tchernia G; Lejeune F; Boccara JF; Denavit MF; Dommergues JP; Bernaudin F
J Pediatr Hematol Oncol; 1996 Feb; 18(1):59-62. PubMed ID: 8556372
[TBL] [Abstract][Full Text] [Related]
24. Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syndrome.
Shimada A; Xu G; Toki T; Kimura H; Hayashi Y; Ito E
Blood; 2004 Jan; 103(1):366. PubMed ID: 14684662
[No Abstract] [Full Text] [Related]
25. A 15q24 microdeletion in transient myeloproliferative disease (TMD) and acute megakaryoblastic leukaemia (AMKL) implicates PML and SUMO3 in the leukaemogenesis of TMD/AMKL.
Haemmerling S; Behnisch W; Doerks T; Korbel JO; Bork P; Moog U; Hentze S; Grasshoff U; Bonin M; Rieß O; Janssen JW; Jauch A; Bartram CR; Reinhardt D; Koch KA; Bandapalli OR; Kulozik AE
Br J Haematol; 2012 Apr; 157(2):180-7. PubMed ID: 22296450
[TBL] [Abstract][Full Text] [Related]
26. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.
Crispino JD
Pediatr Blood Cancer; 2005 Jan; 44(1):40-4. PubMed ID: 15390312
[TBL] [Abstract][Full Text] [Related]
27. Transient myeloproliferative disorder in Down's syndrome: three cases with megakaryocytic markers.
Sartori PC; Darbyshire PJ
Pediatr Hematol Oncol; 1991; 8(2):139-45. PubMed ID: 1830754
[TBL] [Abstract][Full Text] [Related]
28. Molecular insights into Down syndrome-associated leukemia.
Vyas P; Crispino JD
Curr Opin Pediatr; 2007 Feb; 19(1):9-14. PubMed ID: 17224656
[TBL] [Abstract][Full Text] [Related]
29. WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder.
Hasle H; Lund B; Nyvold CG; Hokland P; Østergaard M
Leuk Res; 2006 May; 30(5):543-6. PubMed ID: 16242775
[TBL] [Abstract][Full Text] [Related]
30. GATA1s goes germline.
Mundschau G; Crispino J
Nat Genet; 2006 Jul; 38(7):741-2. PubMed ID: 16804537
[No Abstract] [Full Text] [Related]
31. Origins of leukaemia in children with Down syndrome.
Hitzler JK; Zipursky A
Nat Rev Cancer; 2005 Jan; 5(1):11-20. PubMed ID: 15630411
[TBL] [Abstract][Full Text] [Related]
32. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
Ge Y; Stout ML; Tatman DA; Jensen TL; Buck S; Thomas RL; Ravindranath Y; Matherly LH; Taub JW
J Natl Cancer Inst; 2005 Feb; 97(3):226-31. PubMed ID: 15687366
[TBL] [Abstract][Full Text] [Related]
33. Improving circulatory disturbance in transient abnormal myelopoiesis.
Koga H; Miyako K; Suga N; Hidaka T; Takahashi N
J Pediatr Hematol Oncol; 2012 May; 34(4):e149-51. PubMed ID: 22134612
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of congenital acute myeloid leukemia (AML-M6) in a premature infant.
van Dongen JC; Dalinghaus M; Kroon AA; de Vries AC; van den Heuvel-Eibrink MM
J Pediatr Hematol Oncol; 2009 Nov; 31(11):853-4. PubMed ID: 19779381
[TBL] [Abstract][Full Text] [Related]
35. [Relapsed acute myeloid leukemia with Down syndrome showing long disease-free survival after bone marrow transplantation].
Daifu T; Kato I; Matubara H; Abe D; Uryu K; Tokumasu M; Umeda K; Watanabe K; Izawa K; Asai K; Nakahata T; Adachi S
Rinsho Ketsueki; 2009 Feb; 50(2):73-7. PubMed ID: 19265297
[TBL] [Abstract][Full Text] [Related]
36. Blasts in transient leukaemia in neonates with Down syndrome differentiate into basophil/mast-cell and megakaryocyte lineages in vitro in association with down-regulation of truncated form of GATA1.
Miyauchi J; Ito Y; Tsukamoto K; Takahashi H; Ishikura K; Sugita K; Miyashita T
Br J Haematol; 2010 Mar; 148(6):898-909. PubMed ID: 20064153
[TBL] [Abstract][Full Text] [Related]
37. Analysis of GATA1 mutations and leukemogenesis in newborns with Down syndrome.
Queiroz LB; Lima BD; Mazzeu JF; Camargo R; Córdoba MS; Q Magalhães I; Martins-de-Sá C; Ferrari I
Genet Mol Res; 2013 Oct; 12(4):4630-8. PubMed ID: 24222239
[TBL] [Abstract][Full Text] [Related]
38. A leukemogenic twist for GATA1.
Look AT
Nat Genet; 2002 Sep; 32(1):83-4. PubMed ID: 12172549
[No Abstract] [Full Text] [Related]
39. [Megakaryoblastic leukemia (acute myelofibrosis): complete remission of a case with low-dose cytosine arabinoside].
Palomera L; García Díez I; Woessner S; Velasco F; Torres A
Sangre (Barc); 1988 Jun; 33(3):232-7. PubMed ID: 3175820
[No Abstract] [Full Text] [Related]
40. Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome.
Kanegane H; Watanabe S; Nomura K; Xu G; Ito E; Miyawaki T
Int J Hematol; 2007 Oct; 86(3):250-2. PubMed ID: 17988992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
